Tetra Pharm Technologies Adopts Rootstock ERP for Digital Strategy
14 Nov 2024 //
BUSINESSWIRE
Tetra Pharm Technologies Relocates to Copenhagen Towers
18 Sep 2024 //
PR NEWSWIRE
Tetra Pharm Kvantify Partner On Endocannabinoid System Drug Discovery
30 May 2024 //
PR NEWSWIRE
Tetra Pharm and Glysious Develop Endocannabinoid Transdermals
24 Apr 2024 //
PR NEWSWIRE
Tetra Pharm Technologies introduces pain relieving drug in the United Kingdom
19 Mar 2024 //
PR NEWSWIRE
Tetra Pharm Technologies advances CB1 antagonist, TPT0701
08 Feb 2024 //
PR NEWSWIRE
Tetra Pharm inaugurates new R&D, manufacturing and production facility
16 Aug 2023 //
PR NEWSWIRE
Tetra announces successful In-Vitro drug release test of new analgesic compound
13 Jun 2023 //
PR NEWSWIRE
Tetra Pharm Technologies strengthens management board
16 May 2023 //
PR NEWSWIRE
Tetra Pharm Technologies launches first product in Germany
03 May 2023 //
BUSINESSWIRE
Tetra Pharm Technologies secures €9M in Series A Round to expand R&D Operations
26 Jan 2023 //
PR NEWSWIRE